Kura Oncology (KURA) Other Gross PP&E Adjustments (2014 - 2026)
Kura Oncology (KURA) reported Other Gross PP&E Adjustments of $3.7 million for Q1 2026, up 262.11% year-over-year from $1.0 million in Q1 2025, and up 155.33% on a QoQ basis from -$6.7 million in Q4 2025.
Kura Oncology (KURA) has 13 years of Other Gross PP&E Adjustments data on file, last reported at $3.7 million in Q1 2026.
- Quarterly Other Gross PP&E Adjustments rose 262.11% year-over-year to $3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 million (up 262.11% YoY) and the FY2025 annual result came in at -$6.7 million, up 32.81% from the prior year.
- Other Gross PP&E Adjustments rose to $3.7 million in Q1 2026 per KURA's latest filing, from -$6.7 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $3.7 million in Q3 2025 and bottomed at -$11.6 million in Q4 2023.
- The 5-year median for Other Gross PP&E Adjustments is -$1.7 million (2024), against an average of -$2.3 million.
- The widest annual swing landed in 2023, when Other Gross PP&E Adjustments sank 1851.63%; it then surged 317.26% in 2025.
- Tracing KURA's Other Gross PP&E Adjustments over 5 years: stood at -$6.3 million in 2022, then plunged by 84.63% to -$11.6 million in 2023, then advanced by 14.7% to -$9.9 million in 2024, then soared by 32.81% to -$6.7 million in 2025, then surged by 155.33% to $3.7 million in 2026.
- Per Business Quant, the three latest KURA Other Gross PP&E Adjustments figures stand at $3.7 million (Q1 2026), -$6.7 million (Q4 2025), and $3.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn | 3.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.69 Mn |
| Mar 31, 2026 | 3.69 Mn |
| Dec 31, 2025 | -6.67 Mn |
| Dec 31, 2025 | -6.67 Mn |
| Sep 30, 2025 | 3.73 Mn |
| Sep 30, 2025 | 3.73 Mn |
| Jun 30, 2025 | -212,000.00 |
| Jun 30, 2025 | -212,000.00 |
| Mar 31, 2025 | -2.28 Mn |
| Mar 31, 2025 | -2.28 Mn |
| Dec 31, 2024 | -9.92 Mn |
| Dec 31, 2024 | -9.92 Mn |
| Sep 30, 2024 | -1.72 Mn |
| Sep 30, 2024 | -1.72 Mn |
| Jun 30, 2024 | -2.02 Mn |
| Jun 30, 2024 | -2.02 Mn |
| Mar 31, 2024 | -2.33 Mn |
| Mar 31, 2024 | -2.33 Mn |
| Dec 31, 2023 | -11.63 Mn |
| Dec 31, 2023 | -11.63 Mn |
| Sep 30, 2023 | -2.99 Mn |
| Sep 30, 2023 | -2.99 Mn |
| Jun 30, 2023 | 1.34 Mn |
| Jun 30, 2023 | 1.34 Mn |
| Mar 31, 2023 | 788,000.00 |
| Mar 31, 2023 | 788,000.00 |
| Dec 31, 2022 | -6.30 Mn |
| Dec 31, 2022 | -6.30 Mn |
| Sep 30, 2022 | -153,000.00 |
| Sep 30, 2022 | -153,000.00 |
| Jun 30, 2022 | -969,000.00 |
| Jun 30, 2022 | -969,000.00 |
| Mar 31, 2022 | -1.56 Mn |
| Mar 31, 2022 | -1.56 Mn |
| Dec 31, 2021 | -6.90 Mn |
| Dec 31, 2021 | -6.90 Mn |
| Sep 30, 2021 | -2.58 Mn |
| Sep 30, 2021 | -2.58 Mn |
| Jun 30, 2021 | -2.63 Mn |
| Jun 30, 2021 | -2.63 Mn |
| Mar 31, 2021 | -3.44 Mn |
| Mar 31, 2021 | -3.44 Mn |
| Dec 31, 2020 | -6.63 Mn |
| Dec 31, 2020 | -6.63 Mn |
| Sep 30, 2020 | -4.43 Mn |
| Sep 30, 2020 | -4.43 Mn |
| Jun 30, 2020 | -3.34 Mn |
| Jun 30, 2020 | -3.34 Mn |
| Mar 31, 2020 | -1.30 Mn |
| Mar 31, 2020 | -1.30 Mn |
| Dec 31, 2019 | -2.20 Mn |
| Dec 31, 2019 | -2.20 Mn |
| Sep 30, 2019 | -357,000.00 |
| Sep 30, 2019 | -357,000.00 |
| Jun 30, 2019 | -477,000.00 |
| Jun 30, 2019 | -477,000.00 |
| Mar 31, 2019 | -100,000.00 |
| Mar 31, 2019 | -100,000.00 |
| Dec 31, 2018 | -1.33 Mn |
| Dec 31, 2018 | -1.33 Mn |
| Dec 31, 2017 | -509,000.00 |
| Dec 31, 2017 | -509,000.00 |
| Dec 31, 2016 | -175,000.00 |
| Dec 31, 2016 | -175,000.00 |
| Dec 31, 2015 | 92,000.00 |
| Dec 31, 2015 | 92,000.00 |
| Sep 30, 2015 | 92,000.00 |
| Sep 30, 2015 | 92,000.00 |
| Jun 30, 2015 | 66,000.00 |
| Jun 30, 2015 | 66,000.00 |
| Mar 31, 2015 | 38,000.00 |
| Mar 31, 2015 | 38,000.00 |
| Dec 31, 2014 | 28,000.00 |
| Dec 31, 2014 | 28,000.00 |